These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 4433667)

  • 21. Antibody-dependent lymphoid cell-mediated cytotoxicity: role of complement.
    Van Boxel JA; Paul WE; Green I; Frank MM
    J Immunol; 1974 Jan; 112(1):398-403. PubMed ID: 4812178
    [No Abstract]   [Full Text] [Related]  

  • 22. Adoptive immunotherapy of cancer: accomplishments and prospects.
    Rosenberg SA
    Cancer Treat Rep; 1984 Jan; 68(1):233-55. PubMed ID: 6362866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunotherapy of murine leukemia. II. Effect of passive serum therapy on Friend murine leukemia virus-induced hematologic and coagulation parameters.
    Sanfilippo F; Kao KJ; Pizzo SV; Collins JJ
    J Natl Cancer Inst; 1980 Mar; 64(3):547-53. PubMed ID: 6928240
    [No Abstract]   [Full Text] [Related]  

  • 24. [Antibodies to the autologous tumor cells in tumor induction in mice using methylcholanthrene].
    Vetrova EP; Fedorovskaia MI; Kaminskaia LP; Umanskiĭ IuA
    Vopr Onkol; 1974; 20(3):59-62. PubMed ID: 4612978
    [No Abstract]   [Full Text] [Related]  

  • 25. Demonstration of natural antibodies in normal rabbit serum with similar specificity pattern as mouse natural killer cells.
    Grönberg A; Hansson M; Kiessling R; Andersson B; Kärre K; Roder J
    J Natl Cancer Inst; 1980 May; 64(5):1113-9. PubMed ID: 6966004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The systemic administration of purified interleukin 2 enhances the ability of sensitized murine lymphocytes to cure a disseminated syngeneic lymphoma.
    Donohue JH; Rosenstein M; Chang AE; Lotze MT; Robb RJ; Rosenberg SA
    J Immunol; 1984 Apr; 132(4):2123-8. PubMed ID: 6607956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guinea pig tumor-specific natural antibodies in normal rabbit sera.
    Borsos T; Oanian SH
    J Natl Cancer Inst; 1974 Dec; 53(6):1827-9. PubMed ID: 4436873
    [No Abstract]   [Full Text] [Related]  

  • 28. Adoptive immunotherapy of established syngeneic solid tumors: role of T lymphoid subpopulations.
    Rosenstein M; Eberlein TJ; Rosenberg SA
    J Immunol; 1984 Apr; 132(4):2117-22. PubMed ID: 6607955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor localization of 131-I-labeled antibodies by radionuclide inaging.
    Ghose T; Tal J; Aquino J; Guclu A; Norvell S; MacDonald A
    Radiology; 1975 Aug; 116(02):445-8. PubMed ID: 1153748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibodies in the treatment of lymphoma.
    Leonard JP
    Clin Adv Hematol Oncol; 2004 Apr; 2(4):210-1. PubMed ID: 16163182
    [No Abstract]   [Full Text] [Related]  

  • 31. Mechanism of B cell lymphoma immunotherapy with passive xenogeneic anti-idiotype serum.
    Lanier LL; Babcock GF; Raybourne RB; Arnold LW; Warner NL; Haughton G
    J Immunol; 1980 Oct; 125(4):1730-6. PubMed ID: 6997386
    [No Abstract]   [Full Text] [Related]  

  • 32. Therapy of mouse lymphoma with monoclonal antibodies to glycolipid: selection of low antigenic variants in vivo.
    Young WW; Hakomori SI
    Science; 1981 Jan; 211(4481):487-9. PubMed ID: 7455688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A naturally occurring complement dependent human IgM macroglobulin inhibitory to Ehrlich ascites tumor cells.
    Goff MM; Armentrout SA
    J Clin Lab Immunol; 1982 Dec; 9(3):163-7. PubMed ID: 7166749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of antibody in tumor immunity.
    Economou JS
    Surg Gynecol Obstet; 1981 Sep; 153(3):417-31. PubMed ID: 7268622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Tumor immunology].
    Milas L; Silobrcić V
    Lijec Vjesn; 1970; 92(1):5-33. PubMed ID: 4932237
    [No Abstract]   [Full Text] [Related]  

  • 36. Antibody activity and complement-mediated solubilization of precipitates during the immune response.
    Stassen FL; Beek CJ
    Immunology; 1982 Jun; 46(2):289-95. PubMed ID: 7084992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eradication of tumour cells by successive injections of allogeneic immune and hyperimmune peritoneal cells in a murine lymphoma system.
    Dullens HF; Woutersen RA; de Weger RA; Den Otter W
    Eur J Cancer (1965); 1974 Nov; 10(11):701-6. PubMed ID: 4478884
    [No Abstract]   [Full Text] [Related]  

  • 38. Use of antibodies against tumor-associated antigens for cancer diagnosis and treatment.
    Ghose T; Ramakrishnan S; Kulkarni P; Blair AH; Vaughan K; Nolido H; Norvell ST; Belitsky P
    Transplant Proc; 1981 Dec; 13(4):1970-2. PubMed ID: 7330980
    [No Abstract]   [Full Text] [Related]  

  • 39. Deoxyribonucleic acid (DNA) encoding a pan-major histocompatibility complex class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapy.
    Teramoto K; Kontani K; Ozaki Y; Sawai S; Tezuka N; Nagata T; Fujino S; Itoh Y; Taguchi O; Koide Y; Asai T; Ohkubo I; Ogasawara K
    Cancer Res; 2003 Nov; 63(22):7920-5. PubMed ID: 14633722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal antibodies in cancer therapy.
    Oldham RK
    J Clin Oncol; 1983 Sep; 1(9):582-90. PubMed ID: 6366145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.